Related Articles
HER2<sup>+</sup> advanced gastric cancer: Current state and opportunities (Review)
Targeted therapy in HER2‑positive breast cancer (Review)
Tyrosine kinase inhibitors in breast cancer (Review)
Molecular characterization as a target for cancer therapy in relation to orphan status disorders (Review)
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)